Cargando…

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation

Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7 induction and high‐dose cytarabine consolidation, with clofarabine (3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gill, Harinder, Yim, Rita, Pang, Herbert H., Lee, Paul, Chan, Thomas S. Y., Hwang, Yu‐Yan, Leung, Garret M. K., Ip, Ho‐Wan, Leung, Rock Y. Y., Yip, Sze‐Fai, Kho, Bonnie, Lee, Harold K. K., Mak, Vivien, Chan, Chi‐Chung, Lau, June S. M., Lau, Chi‐Kuen, Lin, Shek‐Yin, Wong, Raymond S. M., Li, Wa, Ma, Edmond S. K., Li, Jun, Panagiotou, Gianni, Sim, Joycelyn P. Y., Lie, Albert K. W., Kwong, Yok‐Lam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221314/ https://www.ncbi.nlm.nih.gov/pubmed/32187883 http://dx.doi.org/10.1002/cam4.2865

Ejemplares similares

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011)

Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine
por: Hwang, Yu-Yan, et al.
Publicado: (2012)

Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
por: Nishi, Rie, et al.
Publicado: (2020)

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
por: Anderson, Rebecca, et al.
Publicado: (2022)

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
por: Ikezoe, Takayuki, et al.
Publicado: (2022)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Histiocytic sarcoma simulating immune thrombocytopenic purpura
por: Sim, Joycelyn, et al.
Publicado: (2012)

Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study
por: van Eijkelenburg, Natasha K.A., et al.
Publicado: (2018)

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia
por: Crobu, Valeria, et al.
Publicado: (2019)

Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
por: Patzke, Ciera L., et al.
Publicado: (2020)

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia
por: Canaani, Jonathan, et al.
Publicado: (2020)

Use of clofarabine for acute childhood leukemia
por: Pession, A, et al.
Publicado: (2010)

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines
por: Valdez, B C, et al.
Publicado: (2014)

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
por: Wang, Amy Y., et al.
Publicado: (2018)

Clofarabine exerts antileukemic activity against cytarabine‐resistant B‐cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression
por: Huang, Meixian, et al.
Publicado: (2018)

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain
por: Tang, Hoi Ki Karen, et al.
Publicado: (2022)

Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
por: Leung, T. Y. M., et al.
Publicado: (2020)

Seasonality of tuberculosis in intermediate endemicity setting dominated by reactivation diseases in Hong Kong
por: Lau, Leonia Hiu Wan, et al.
Publicado: (2021)

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
por: Halpern, Anna B., et al.
Publicado: (2023)

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
por: Gill, Harinder, et al.
Publicado: (2016)

Genetic association between germline JAK2 polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case–control study
por: Koh, Su Pin, et al.
Publicado: (2014)

Dual anti-HIV mechanism of clofarabine
por: Daly, Michele B., et al.
Publicado: (2016)

Electronic School Absenteeism Monitoring and Influenza Surveillance, Hong Kong
por: Cheng, Calvin K.Y., et al.
Publicado: (2012)

Reliability and validity of the Chinese (Queen Mary Hospital, Hong Kong version) of the Disabilities of the Arm, Shoulder and Hand on patients with upper extremity musculoskeletal disorders in Hong Kong
por: K.Y. Chan, Rebecca, et al.
Publicado: (2019)

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
por: Zeidner, Joshua F., et al.
Publicado: (2021)

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
por: Braess, Jan, et al.
Publicado: (2018)

[(18)F] Clofarabine for PET Imaging of Hepatocellular Carcinoma
por: Sergeeva, Olga, et al.
Publicado: (2019)

Cholangiographic Features in the Diagnosis and Management of Obstructive Icteric Type Hepatocellular Carcinoma
por: Lau, W. Y., et al.
Publicado: (2000)

Treating refractory leukemias in childhood, role of clofarabine
por: Harned, Theresa M, et al.
Publicado: (2008)

Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study
por: Lu, A, et al.
Publicado: (2016)

First report of chronic implant-related septic arthritis and osteomyelitis due to Kytococcus schroeteri and a review of human K. schroeteri infections
por: Chan, J. F. W., et al.
Publicado: (2012)

Adolescents’ attitudes to the COVID-19 vaccination
por: Wong, W.H.S., et al.
Publicado: (2022)

Examining the Moderating Role of Patient Enablement on the Relationship Between Health Anxiety and Psychosomatic Distress: A Cross-Sectional Study at a Traditional Chinese Medicine Outpatient Clinic in Hong Kong
por: Chan, Celia H. Y., et al.
Publicado: (2020)

Clinico-pathological correlations and outcomes of de novo glomerular diseases in patients after haematopoietic stem cell transplantation
por: Yap, Desmond Y H, et al.
Publicado: (2022)

Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters
por: Miller, Siennah R., et al.
Publicado: (2021)

Exploring the Presence of Humanoid Social Robots at Home and Capturing Human-Robot Interactions with Older Adults: Experiences from Four Case Studies
por: Leung, Angela Y. M., et al.
Publicado: (2022)

Genome Sequence of a Human Norovirus GII.4 Hong Kong[P31] Variant in Hong Kong, China
por: Tse, Erin H. Y., et al.
Publicado: (2020)

Impact of COVID-19 on seizure-related emergency attendances and hospital admissions — A territory-wide observational study()()()
por: Leung, William C.Y., et al.
Publicado: (2021)

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
por: Chim, Chor Sang, et al.
Publicado: (2012)

INDELseek: detection of complex insertions and deletions from next-generation sequencing data
por: Au, Chun Hang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1vm5sqrb4m91eujgcf38di6t47